19 November 2017
News and Views
Links and Services
Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss, finds this month's publication of Gastroenterology.
An association between proton-pump inhibitor (PPI) use and hip fracture has been shown.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors